Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Condition:   Asthma
Interventions:   Drug: QAV680;   Drug: QAV680 Placebo
Sponsor:   Novartis Pharmaceuticals
Terminated – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.